about
Clinical Efficacy of Therapy with Recombinant Human Interferon α1b in Hand, Foot, and Mouth Disease with Enterovirus 71 InfectionThe molecular basis for differential type I interferon signaling.STING-Dependent 2'-5' Oligoadenylate Synthetase-Like Production Is Required for Intracellular Mycobacterium leprae Survival.Mapping Determinants of Cytokine Signaling via Protein EngineeringPlasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Fine Tuning of a Type 1 Interferon Antagonist.
@en
type
label
Fine Tuning of a Type 1 Interferon Antagonist.
@en
prefLabel
Fine Tuning of a Type 1 Interferon Antagonist.
@en
P2093
P2860
P1433
P1476
Fine Tuning of a Type 1 Interferon Antagonist.
@en
P2093
Daniel Harari
Doron Levin
Gideon Schreiber
Nanaocha Sharma
Victoria Urin
P2860
P304
P356
10.1371/JOURNAL.PONE.0130797
P407
P577
2015-07-09T00:00:00Z